文献速递帕金森病与运动障碍

早发型帕金森病自主神经功能障碍与死亡风险

Autonomic Dysfunction and Risk of Mortality in Early-Onset Parkinson's Disease.
PubMed 文献 · Ann Neurol · 2025-12-31

该研究基于Mayo Clinic 1990-2022年829例早发型帕金森病(EOPD)患者及829例年龄性别匹配对照,发现63.4%患者存在自主神经症状,且91.4%在运动症状后出现。在EOPD人群中,任何自主神经症状与死亡风险增加2.71倍相关,每增加一个症状风险增加50%。

要点

  • 自主神经症状多出现在运动症状之后(91.4%),与晚发型帕金森病的前驱期表现不同。
  • 自主神经症状与死亡风险增加相关,每增加一个症状死亡风险增加50%。

核心结论

  • EOPD患者中自主神经功能障碍患病率为63.4%,且与死亡风险增加相关。
  • 任何自主神经症状与死亡风险增加2.71倍相关,每增加一个症状风险增加50%(p < 0.001)。
  • 便秘和直立不耐受分别与死亡风险增加3.22倍和2.78倍相关。

研究设计与样本

  • 回顾性队列研究,纳入Mayo Clinic Health System 1990-2022年发病年龄<50岁的帕金森病患者829例及年龄性别匹配对照829例。
  • 通过病历回顾确认临床诊断并评估自主神经症状的存在及与帕金森病发病的时间关系。

主要发现

  • EOPD患者自主神经症状患病率63.4%,对照组27.0%。
  • 自主神经症状在91.4%的患者中先于运动症状出现。
  • 中位发病年龄42岁(IQR 37-46岁)。

临床怎么用

  • 对EOPD患者应系统评估自主神经症状,因其与死亡风险增加独立相关。
  • 便秘和直立不耐受可作为EOPD患者死亡风险增高的警示指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dysautonomia affects many patients with Parkinson's disease and correlates with increased cardiovascular mortality. We describe the frequency and onset time of autonomic dysfunction relative to disease onset in early-onset Parkinson's disease (EOPD) and explore its association with mortality. METHODS: We identified all incident Parkinson cases with motor-symptom onset before age 50 years evaluated at the Mayo Clinic Health System (1990-2022) including sex- and age-matched controls for each patient. Medical record review confirmed clinical diagnosis and assessed the presence and onset of autonomic symptoms, relative to Parkinson onset. RESULTS: We included 829 patients with EOPD and 829 healthy controls. The median age at disease onset was 42 years (interquartile range [IQR] = 37-46 years). Autonomic symptoms were present in 63.4% of patients, compared with 27.0% of unaffected controls, and proceeded motor symptoms in 91.4%. Forty-seven percent of patients with early-onset Parkinson's disease had constipation, 27.4% had bladder urgency, 19.3% had orthostatic intolerance, and 15.4% had sweat dysfunction. Among male patients, 36.8% had erectile dysfunction. In our EOPD population only, the presence of any autonomic-impairment symptoms correlated with a 2.71-fold increased mortality risk; each additional reported symptom increased the relative mortality risk by 50% (p < 0.001). Patients with constipation or orthostatic intolerance had a 3.22- and 2.78-fold higher mortality than patients without these symptoms. INTERPRETATION: Autonomic impairment affects 63.4% of patients with EOPD and carries a 3-fold higher mortality risk, which increases with every additional autonomic symptom reported. In our cohort, autonomic symptoms appeared most commonly after motor onset, contrasting with prodromal autonomic impairment seen in late-onset Parkinson's disease (LOPD). ANN NEUROL 2026;99:964-975.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Piat C, Mullan AF, Ghoniem K, et al. Autonomic Dysfunction and Risk of Mortality in Early-Onset Parkinson's Disease. Ann Neurol. 2025. PMID: 41474120. doi:10.1002/ana.78143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。